Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081711 | 12708171 | 1 | I | 20160830 | 20160901 | 20160901 | EXP | US-PFIZER INC-2016411378 | PFIZER | ADRA, N.. HIGH-DOSE CHEMOTHERAPY (HDCT) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM CELL TRANSPLANT (PBSCT) FOR RELAPSED METASTATIC GERM-CELL TUMORS (MGCT): THE INDIANA UNIVERSITY (IU) EXPERIENCE.. JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15) | 0.00 | Y | 0.00000 | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081711 | 12708171 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | 700 MG/M2, CYCLIC (FOR 3 CONSECUTIVE DAYS) | 76517 | 700 | MG/M**2 | |||||||||
| 127081711 | 12708171 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | 750 MG/M2, CYCLIC (FOR 3 CONSECUTIVE DAYS) | 0 | 750 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127081711 | 12708171 | 1 | Germ cell cancer metastatic |
| 127081711 | 12708171 | 2 | Germ cell cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127081711 | 12708171 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127081711 | 12708171 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |